-
Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months
02 Feb 2026 13:31 GMT
… TITAN trial received a concomitant gonadotropin-releasing hormone agonist (GnRH) analog or had a … seizure during treatment. It is unknown whether anti-epileptic medications will prevent … (SJS/TEN), and drug reaction with eosinophilia and systemic …
-
A Novel Nomogram for Predicting Gonadotropin-Releasing Hormone Analogue Treatment Outcome in Girls with Idiopathic Central Precocious Puberty
23 Jan 2026 21:28 GMT
… therapeutic targets and drugs. In the aspect of medical resource allocation, the … , et al. Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic … Long-term effects of GnRH agonist treatment on body mass index in …
-
Medicus Pharma lowers royalty burden on prostate cancer drug Teverelix
22 Jan 2026 19:41 GMT
… a next-generation, long-acting gonadotropin-releasing hormone (GnRH) antagonist being developed primarily for … flare, the company said.
Medicus said the drug’s mechanism may be … platform for the non-invasive treatment of basal cell carcinoma. Enrollment …
-
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
22 Jan 2026 18:00 GMT
… Pharma Companies Rigorously Develop Drugs for Market Entry | … Subcutaneous
TU2670
TiumBio
II
Gonadotropin-releasing hormone (GnRH) receptor antagonist
Oral
Nibrozetone … reach out @ Medication for Endometriosis Treatment Related Reports Endometriosis …
-
Evolving PCOS Management: From Symptom Control to Phenotype-Targeted Therapy
03 Feb 2026 23:50 GMT
… experimental evidence demonstrating altered gonadotropin-releasing hormone (GnRH) pulsatility following microbiota modulation … establishing these pathways as druggable targets.61 This mechanistic … of traditional chinese medicine in adjuvant treatment of type …
-
Medicus Pharma advances Teverelix program, set to present Phase 1 data at...
13 Jan 2026 05:36 GMT
… data on its long-acting gonadotropin-releasing hormone (GnRH) antagonist Teverelix at the … immediately block GnRH receptors. Medicus noted that, unlike GnRH agonists, the drug does … doxorubicin for the treatment of basal cell carcinoma.
Medicus said that …
-
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women
12 Jan 2026 12:30 GMT
… on Teverelix, its long-acting gonadotropin-releasing hormone (GnRH) antagonist, have been accepted … drug-related serious adverse events and only mild-to-moderate treatment … 615-9162
adjokovic@medicuspharma.com About Medicus Pharma Ltd. Medicus Pharma Ltd. ( …
-
Exosomes for Polycystic Ovary Syndrome Treatment: Mechanisms and Therapeutic Potential
09 Jan 2026 21:59 GMT
… It causes a persistently rapid gonadotropin-releasing hormone (GnRH) pulse frequency, leading to … acetate or drospirenone). These medications can both suppress excessive androgen … for disease treatment. Exosomes are considered ideal drug delivery carriers …
-
Research finds GnRH antagonist more effective than PPOS in boosting oocyte retrieval
02 Jan 2026 11:06 GMT
… researchers have reported that the gonadotropin-releasing hormone (GnRH) antagonist protocol results in … including Bayesian analysis. Women treated with the antagonist protocol retrieved … could help clinicians tailor treatment plans more precisely, leading …
-
Forest dept to source leopard birth control drug from abroad
30 Dec 2025 00:52 GMT
… years will be selected after medical screening. “Female leopards between three … level, covering animal selection, drug administration and post-treatment monitoring. “The biggest … porcine zona pellucida (PZP) or GnRH-based formulations like GonaCon, neither …
About
© 1995-2026